Masoabi Sefojane: Are Our Systems in the Global South Evolving at the Same Pace as Our Science?
Masoabi Sefojane, Geographic Expansion Lead, Africa and Asia Pacific at MicroHealth , shared a post on LinkedIn:
“Last week at the World Federation of Hemophilia , World Congress 2026 in Kuala Lumpur, I had the opportunity to contribute as a speaker, session chair, and delegate representing South Africa through the South African Haemophilia Foundation.
I presented in a session exploring how we better engage older people with bleeding disorders, and moderated a poster session that reflected the breadth of global research and innovation in our field.
Across the Congress, one thing was clear, there is strong momentum around the next generation of therapies and treatment pipelines.
The science is evolving, and the possibilities for patient outcomes are expanding.
At a global level, this is encouraging.
But it also raises an important question:
Are our systems in the global south evolving at the same pace as our science?”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice